367 related articles for article (PubMed ID: 23562839)
1. The fat side of prostate cancer.
Zadra G; Photopoulos C; Loda M
Biochim Biophys Acta; 2013 Oct; 1831(10):1518-32. PubMed ID: 23562839
[TBL] [Abstract][Full Text] [Related]
2. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer.
Costello LC; Franklin RB
Prostate; 1998 Jun; 35(4):285-96. PubMed ID: 9609552
[TBL] [Abstract][Full Text] [Related]
3. Altered metabolism and mitochondrial genome in prostate cancer.
Dakubo GD; Parr RL; Costello LC; Franklin RB; Thayer RE
J Clin Pathol; 2006 Jan; 59(1):10-6. PubMed ID: 16394275
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Progression: as a Matter of Fats.
Scaglia N; Frontini-López YR; Zadra G
Front Oncol; 2021; 11():719865. PubMed ID: 34386430
[TBL] [Abstract][Full Text] [Related]
5. The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives.
Wang W; Bai L; Li W; Cui J
Front Oncol; 2020; 10():605154. PubMed ID: 33364199
[TBL] [Abstract][Full Text] [Related]
6. Lipid metabolism in prostate cancer.
Wu X; Daniels G; Lee P; Monaco ME
Am J Clin Exp Urol; 2014; 2(2):111-20. PubMed ID: 25374912
[TBL] [Abstract][Full Text] [Related]
7. A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.
Zadra G; Photopoulos C; Tyekucheva S; Heidari P; Weng QP; Fedele G; Liu H; Scaglia N; Priolo C; Sicinska E; Mahmood U; Signoretti S; Birnberg N; Loda M
EMBO Mol Med; 2014 Apr; 6(4):519-38. PubMed ID: 24497570
[TBL] [Abstract][Full Text] [Related]
8. AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer.
Priolo C; Pyne S; Rose J; Regan ER; Zadra G; Photopoulos C; Cacciatore S; Schultz D; Scaglia N; McDunn J; De Marzo AM; Loda M
Cancer Res; 2014 Dec; 74(24):7198-204. PubMed ID: 25322691
[TBL] [Abstract][Full Text] [Related]
9. Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness.
Yue S; Li J; Lee SY; Lee HJ; Shao T; Song B; Cheng L; Masterson TA; Liu X; Ratliff TL; Cheng JX
Cell Metab; 2014 Mar; 19(3):393-406. PubMed ID: 24606897
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis.
Deep G; Schlaepfer IR
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27384557
[TBL] [Abstract][Full Text] [Related]
11. Link between obesity and cancer: role of triglyceride/free fatty acid cycling.
Gong Y; Dou LJ; Liang J
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2808-20. PubMed ID: 25339474
[TBL] [Abstract][Full Text] [Related]
12. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.
Chen M; Zhang J; Sampieri K; Clohessy JG; Mendez L; Gonzalez-Billalabeitia E; Liu XS; Lee YR; Fung J; Katon JM; Menon AV; Webster KA; Ng C; Palumbieri MD; Diolombi MS; Breitkopf SB; Teruya-Feldstein J; Signoretti S; Bronson RT; Asara JM; Castillo-Martin M; Cordon-Cardo C; Pandolfi PP
Nat Genet; 2018 Feb; 50(2):206-218. PubMed ID: 29335545
[TBL] [Abstract][Full Text] [Related]
13. The Metabolic Phenotype of Prostate Cancer.
Eidelman E; Twum-Ampofo J; Ansari J; Siddiqui MM
Front Oncol; 2017; 7():131. PubMed ID: 28674679
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues.
Myers JS; von Lersner AK; Sang QX
J Cancer; 2016; 7(11):1452-64. PubMed ID: 27471561
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts.
Schlaepfer IR; Glodé LM; Hitz CA; Pac CT; Boyle KE; Maroni P; Deep G; Agarwal R; Lucia SM; Cramer SD; Serkova NJ; Eckel RH
Mol Imaging Biol; 2015 Aug; 17(4):529-38. PubMed ID: 25561013
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
Zadra G; Ribeiro CF; Chetta P; Ho Y; Cacciatore S; Gao X; Syamala S; Bango C; Photopoulos C; Huang Y; Tyekucheva S; Bastos DC; Tchaicha J; Lawney B; Uo T; D'Anello L; Csibi A; Kalekar R; Larimer B; Ellis L; Butler LM; Morrissey C; McGovern K; Palombella VJ; Kutok JL; Mahmood U; Bosari S; Adams J; Peluso S; Dehm SM; Plymate SR; Loda M
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):631-640. PubMed ID: 30578319
[TBL] [Abstract][Full Text] [Related]
17. Metabolic targets for potential prostate cancer therapeutics.
Twum-Ampofo J; Fu DX; Passaniti A; Hussain A; Siddiqui MM
Curr Opin Oncol; 2016 May; 28(3):241-7. PubMed ID: 26907571
[TBL] [Abstract][Full Text] [Related]
18. Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered.
Kinlaw WB; Baures PW; Lupien LE; Davis WL; Kuemmerle NB
J Cell Physiol; 2016 Oct; 231(10):2128-41. PubMed ID: 26844415
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase (AMPK) as a potential therapeutic target independent of PI3K/Akt signaling in prostate cancer.
Choudhury Y; Yang Z; Ahmad I; Nixon C; Salt IP; Leung HY
Oncoscience; 2014; 1(6):446-56. PubMed ID: 25594043
[TBL] [Abstract][Full Text] [Related]
20. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.
Tennakoon JB; Shi Y; Han JJ; Tsouko E; White MA; Burns AR; Zhang A; Xia X; Ilkayeva OR; Xin L; Ittmann MM; Rick FG; Schally AV; Frigo DE
Oncogene; 2014 Nov; 33(45):5251-61. PubMed ID: 24186207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
